The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 2, 2011, Pages 431-444

  Tsallas, Antonia ^a   Jackson, John ^a   Burt, Helen ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Docetaxel; Intravesical drug delivery; Paclitaxel; Superficial bladder cancer

Indexed keywords

ALCOHOL; COPOLYMER; CREMOPHOR; DOCETAXEL; METHOXY POLYETHYLENEGLYCOL BLOCK POLYCAPROLACTONE; METHOXY POLYETHYLENEGLYCOL BLOCK POLYGLACTIN; NANOPARTICLE; PACLITAXEL; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EXPOSURE; DRUG FORMULATION; DRUG UPTAKE; EX VIVO STUDY; MICELLE; NONHUMAN; PRIORITY JOURNAL; SWINE;

ADMINISTRATION, INTRAVESICAL; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; DRUG CARRIERS; DRUG COMPOUNDING; GLYCEROL; MALE; MICELLES; NANOPARTICLES; PACLITAXEL; PHARMACEUTICAL VEHICLES; POLYESTERS; POLYETHYLENE GLYCOLS; POLYSORBATES; SWINE; TAXOIDS; TISSUE DISTRIBUTION; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 79960909238     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1499-2     Document Type: Article

References (36)

1. JL Au RA Badalament MG Wientjes DC Young JA Warner PL Venema DL Pollifrone JD Harbrecht JL Chin SP Lerner BJ Miles 2001 Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial J Natl Cancer Inst 93 597 604 11309436 10.1093/jnci/93.8.597 1:CAS:528: DC%2BD3MXjsV2rur8%3D (Pubitemid 32409627)
2. JL Au J Kalns Y Gan MG Wientjes 1997 Pharmacologic effects of paclitaxel in human bladder tumors Cancer Chemother Pharmacol 41 69 74 9443616 10.1007/s002800050709 1:CAS:528:DyaK1cXls1Srug%3D%3D (Pubitemid 28093952)
3. RA Badalament RN Farah 1997 Treatment of superficial bladder cancer with intravesical chemotherapy Semin Surg Oncol 13 335 341 9259089 10.1002/(SICI)1098-2388(199709/10)13:5<335::AID-SSU7>3.0.CO;2-E 1:STN:280:DyaK2svgtlOltg%3D%3D (Pubitemid 27332856)
4. LJ Barlow JM McKiernan MC Benson 2009 The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience World J Urol 27 331 335 19214528 10.1007/s00345-009-0377-1 1:CAS:528:DC%2BD1MXntVSrsrw%3D
5. CC Boring TS Squires T Tong S Montgomery 1994 Cancer statistics, 1994 CA Cancer J Clin 44 7 26 8281473 10.3322/canjclin.44.1.7 1:STN:280: DyaK2c7gvVygsA%3D%3D
6. C Bouffioux KH Kurth A Bono W Oosterlinck CB Kruger M De Pauw R Sylvester 1995 Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European organization for research and treatment of cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European organization for research and treatment of cancer genitourinary group J Urol 153 934 941 7853578 10.1016/S0022-5347(01)67608-0 1:STN:280:DyaK2M7ls1KktA%3D%3D
7. HM Burt X Zhang P Toleikis L Embree W Hunter 1999 development of copolymers of poly(DL-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel Colloids Surf B Biointerfaces 16 161 171 10.1016/S0927-7765(99)00067-3 1:CAS:528:DyaK1MXnvFylurs%3D (Pubitemid 29486803)
8. D Chen D Song MG Wientjes JL Au 2003 Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel Clin Cancer Res 9 363 369 12538489 1:CAS:528:DC%2BD3sXnt1Oqsw%3D%3D (Pubitemid 36109753)
9. JT Dalton MG Wientjes RA Badalament JR Drago JL Au 1991 Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients Cancer Res 51 5144 5152 1913640 1:STN:280:DyaK38%2FgsFChtA%3D%3D
10. A De Ascentiis J De Grazia C Bowman P Colombo NA Peppas 1995 Mucoadhesion of poly(2-hydroxyethyl methacrylate) is improved when linear poly(ethylene oxide) chains are added to the polymer network J Control Release 33 197 201 10.1016/0168-3659(94)00087-B 1:CAS:528:DyaK2MXjt1Srtb4%3D
11. D Galabova B Tuleva D Spasova 1996 Permeabilization of Yarrowia lipolytica cells by Triton X-100 Enzyme Microb Technol 18 18 22 10.1016/0141-0229(96)00063-4 1:CAS:528:DyaK28XosFyksg%3D%3D (Pubitemid 26059407)
12. R Gref M Luck P Quellec M Marchand E Dellacherie S Harnisch T Blunk RH Muller 2000 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf B Biointerfaces 18 301 313 10915952 10.1016/S0927-7765(99)00156-3 1:CAS:528:DC%2BD3cXltVOltbo%3D (Pubitemid 30479870)
13. BA Hadaschik MG ter Borg J Jackson RD Sowery AI So HM Burt ME Gleave 2008 Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer BJU Int 101 1347 1355 18384637 10.1111/j.1464-410X.2008.07571.x 1:CAS:528:DC%2BD1cXnsFOmsrY%3D (Pubitemid 351623986)
14. MS Highley AT van Oosterom RA Maes EA De Bruijn 1999 Intravesical drug delivery. Pharmacokinetic and clinical considerations Clin Pharmacokinet 37 59 73 10451783 10.2165/00003088-199937010-00004 1:CAS:528:DyaK1MXls1Wiu7k%3D (Pubitemid 29366760)
15. M Kerec M Bogataj P Veranic A Mrhar 2005 Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium Eur J Pharm Sci 25 113 121 15854807 10.1016/j.ejps.2005.02.003 1:CAS:528:DC%2BD2MXjs1Knurg%3D (Pubitemid 40602201)
16. I Knemeyer MG Wientjes JL Au 1999 Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment Cancer Chemother Pharmacol 44 241 248 10453726 10.1007/s002800050973 1:CAS:528:DyaK1MXkvVyhsLY%3D (Pubitemid 29350180)
17. R Konsoula FA Barile 2005 Correlation of in vitro cytotoxicity with paracellular permeability in Caco-2 cells Toxicol In Vitro 19 675 684 15896555 10.1016/j.tiv.2005.03.006 1:CAS:528:DC%2BD2MXkt1OitL8%3D (Pubitemid 40719542)
18. MA Laudano LJ Barlow AM Murphy DP Petrylak M Desai MC Benson JM McKiernan 2010 Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy Urology 75 134 137 19913890 10.1016/j.urology.2009.06.112
19. WK Lee KD Park YH Kim H Suh JC Park JE Lee K Sun MJ Baek HM Kim SH Kim 2001 Improved calcification resistance and biocompatibility of tissue patch grafted with sulfonated PEO or heparin after glutaraldehyde fixation J Biomed Mater Res 58 27 35 11152994 10.1002/1097-4636(2001)58:1<27::AID-JBM40>3.0. CO;2-2 1:CAS:528:DC%2BD3MXht1Gqurg%3D (Pubitemid 32150698)
20. K Letchford R Liggins H Burt 2008 Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations J Pharm Sci 97 1179 1190 17683080 10.1002/jps.21037 1:CAS:528:DC%2BD1cXivFentbc%3D
21. K Letchford R Liggins KM Wasan H Burt 2009 In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles Eur J Pharm Biopharm 71 196 206 18762253 10.1016/j.ejpb.2008.08.003 1:CAS:528:DC%2BD1MXitVShsLo%3D
22. PU Malmstrom 2003 Intravesical therapy of superficial bladder cancer Crit Rev Oncol Hematol 47 109 126 12900005 10.1016/S1040-8428(03)00075-1 (Pubitemid 36957860)
23. JM McKiernan P Masson AM Murphy M Goetzl CA Olsson DP Petrylak M Desai MC Benson 2006 Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy J Clin Oncol 24 3075 3080 16809732 10.1200/JCO.2005.03.1161 1:CAS:528: DC%2BD28XnslKhs7o%3D (Pubitemid 46638943)
24. C Mugabe BA Hadaschik RK Kainthan DE Brooks AI So ME Gleave HM Burt 2009 Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy BJU Int 103 978 986 19007363 10.1111/j.1464-410X.2008.08132.x 1:CAS:528:DC%2BD1MXksl2qsL4%3D
25. O Nativ M Aronson O Medalia T Moldavsky E Sabo I Ringel V Kravtsov 1997 Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: in vivo and in vitro studies Int J Cancer 70 297 301 9033631 10.1002/(SICI)1097-0215(19970127)70:3<297::AID-IJC9>3.0.CO;2-S 1:CAS:528:DyaK2sXhs1Onu7g%3D (Pubitemid 27099598)
26. W Oosterlinck KH Kurth F Schroder J Bultinck B Hammond R Sylvester 1993 A prospective European organization for research and treatment of cancer genitourinary group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder J Urol 149 749 752 8455236 1:STN:280:DyaK3s3gsValug%3D%3D (Pubitemid 23111060)
27. C Rangel H Niell A Miller C Cox 1994 Taxol and taxotere in bladder cancer: in vitro activity and urine stability Cancer Chemother Pharmacol 33 460 464 7907952 10.1007/BF00686501 1:CAS:528:DyaK2cXls12qsbw%3D (Pubitemid 24082338)
28. Z Shen T Shen MG Wientjes MA O'Donnell JL Au 2008 Intravesical treatments of bladder cancer: review Pharm Res 25 1500 1510 18369709 10.1007/s11095-008- 9566-7 1:CAS:528:DC%2BD1cXmslWnu78%3D
29. AP Soler RD Miller KV Laughlin NZ Carp DM Klurfeld JM Mullin 1999 Increased tight junctional permeability is associated with the development of colon cancer Carcinogenesis 20 1425 1431 10426787 10.1093/carcin/20.8.1425 1:CAS:528:DyaK1MXltlKgtbc%3D (Pubitemid 29385425)
30. D Song MG Wientjes JL Au 1997 Bladder tissue pharmacokinetics of intravesical taxol Cancer Chemother Pharmacol 40 285 292 9225946 10.1007/s002800050660 1:CAS:528:DyaK2sXksVOlu7k%3D (Pubitemid 27276132)
31. Sylvester RJ, Oosterlinck W, van der Meijden AP (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171:2186-2190, quiz 2435 (Pubitemid 38625431)
32. DA Tolley MK Parmar KM Grigor G Lallemand LL Benyon J Fellows LS Freedman RR Hall TB Hargreave K Munson DW Newling B Richards MR Robinson MB Rose PH Smith JL Williams P Whelan 1996 The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up J Urol 155 1233 1238 8632538 10.1016/S0022-5347(01)66226-8 1:CAS:528:DyaK28XltF2lt7g%3D (Pubitemid 26081202)
33. G Tringali L Lisi F Bettella D Renier SM Di Stasi P Navarra 2008 The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm Pharmacol Res 58 340 343 18848989 10.1016/j.phrs.2008.09.008 1:CAS:528:DC%2BD1cXhsVChu77N
34. MG Wientjes RA Badalament JL Au 1996 Penetration of intravesical doxorubicin in human bladders Cancer Chemother Pharmacol 37 539 546 8612307 10.1007/s002800050426 1:CAS:528:DyaK28XisVCqurc%3D (Pubitemid 26080151)
35. M Wirth VE Plattner F Gabor 2009 Strategies to improve drug delivery in bladder cancer therapy Expert Opin Drug Deliv 6 727 744 19538035 10.1517/17425240903022758 1:CAS:528:DC%2BD1MXnslensrY%3D
36. X Zhang J Jackson HM Burt 1996 Development of amphiphilic diblock copolymers as micellar carriers of taxol Int J Pharm 132 195 206 10.1016/0378-5173(95)04386-1 1:CAS:528:DyaK28XjtFSktrc%3D (Pubitemid 26158719)